ipamorelin cjc-1295 before and after Results CJC-1295 + Ipamorelin: Timeline &

Individuals interested in supporting immune health and healthy aging

These peptides work together to stimulate the bodys release of growth hormone in a balanced, controlled manner

US operations referenced on this page relate to warehouse fulfillment and do not represent a separate US manufacturer, clinical provider, or pharmaceutical entity

Other side effects Additional reported side effects include: Joint pain and water retention Muscle and joint aches Headaches and nausea Receptor desensitization with prolonged use Potential suppression of natural GH and IGF-1 production Who should avoid IGF-1 LR3 Certain groups should not use IGF-1 LR3: Anyone with active cancer or tumor history Those with severe insulin resistance or diabetes Pregnant or nursing women Anyone under 25 whose growth plates haven't closed Those with existing hormonal imbalances IGF-1 LR3 is not FDA-approved for general medical use and remains primarily a research compound